Lars Jønson

3.3k citations

36 papers · 1.5k indexed · h-index 21

Impact in

Cancer Research top 5%
- Cancer-related molecular mechanisms research
Dermatology top 5%
- Cutaneous lymphoproliferative disorders research

Papers in ⓘ

Molecular Biology 25
- CRISPR and Genetic Engineering 9
- DNA Repair Mechanisms 6
- RNA Research and Splicing 4
Genetics 14
- BRCA gene mutations in cancer 12
- Genomic variations and chromosomal abnormalities 4

Co-authors: Thomas van Overeem Hansen (14 shared papers)Finn Cilius Nielsen (12 shared papers)Jan Christiansen (3 shared papers)Jonas Vikesaa (2 shared papers)Rehannah Borup (1 shared paper)Ulla M. Wewer (1 shared paper)Anders H. Johnsen (5 shared papers)Bent Ejlertsen (8 shared papers)
Journals: Breast Cancer Research and Treatment (6 papers)Familial Cancer (3 papers)Oncotarget (3 papers)Yeast (1 paper)Transfusion (1 paper)
Partner nations: Denmark United States Greenland

In The Last Decade

Lars Jønson

36 papers receiving 1.5k citations

Peers

Countries citing papers authored by Lars Jønson

Since Specialization

Citations

This map shows the geographic impact of Lars Jønson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Jønson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Jønson more than expected).

Fields of papers citing papers by Lars Jønson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lars Jønson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Jønson. The network helps show where Lars Jønson may publish in the future.

Co-authors

The 25 scholars most cited alongside Lars Jønson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Lars Jønson Line = papers co-authored together Lars Jønson links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	RNA‐binding IMPs promote cell adhesion and invadopodia formation The EMBO Journal ·Jonas Vikesaa, Thomas van Overeem Hansen, Lars Jønson, Rehannah Borup, Ulla M. Wewer, Jan Christiansen, Finn Cilius Nielsen	2006	285
2	Genome‐wide identification of genes required for growth of Saccharomyces cerevisiae under ethanol stress Yeast ·Frank van Voorst, Jens Houghton‐Larsen, Lars Jønson, Morten C. Kielland‐Brandt, Anders Brandt	2006	127
3	STAT5-mediated expression of oncogenic miR-155 in cutaneous T-cell lymphoma Cell Cycle ·Katharina Kopp, Ulrik Ralfkiær, Lise Mette Rahbek Gjerdrum, Rikke Helvad, Ida Pedersen, Thomas Litman, Lars Jønson, Peter Hagedorn, Thorbjørn Krejsgaard, Robert Gniadecki, Charlotte M. Bonefeld, Lone Skov, Carsten Geisler, Mariusz A. Wasik, Elisabeth Ralfkiær, Niels Ødum, Anders Woetmann	2013	112
4	Molecular profiling of tumour budding implicates TGFβ‐mediated epithelial–mesenchymal transition as a therapeutic target in oral squamous cell carcinoma The Journal of Pathology ·DH Jensen, Erik Dabelsteen, Lena Specht, Anne‐Marie Kanstrup Fiehn, MH Therkildsen, Lars Jønson, Jonas Vikesaa, Finn Cilius Nielsen, Christian von Buchwald	2015	104
5	IMP3 RNP Safe Houses Prevent miRNA-Directed HMGA2 mRNA Decay in Cancer and Development Cell Reports ·Lars Jønson, Jan Christiansen, Thomas van Overeem Hansen, Jonas Vikeså, Yohei Yamamoto, Finn Cilius Nielsen	2014	75
6	Jak3, STAT3, and STAT5 inhibit expression of miR-22, a novel tumor suppressor microRNA, in cutaneous T-Cell lymphoma Oncotarget ·Nina A. Sibbesen, Katharina Kopp, Ivan V. Litvinov, Lars Jønson, Andreas Willerslev-Olsen, Simon Fredholm, David L. Petersen, Claudia Nastasi, Thorbjørn Krejsgaard, Lise M. Lindahl, Robert Gniadecki, Nigel P. Mongan, Denis Sasseville, Mariusz A. Wasik, Lars Iversen, Charlotte M. Bonefeld, Carsten Geisler, Anders Woetmann, Niels Ødum	2015	70
7	Large BRCA1 and BRCA2 genomic rearrangements in Danish high risk breast-ovarian cancer families Breast Cancer Research and Treatment ·Thomas van Overeem Hansen, Lars Jønson, Anders Albrechtsen, Mette Klarskov Andersen, Bent Ejlertsen, Finn Cilius Nielsen	2008	57
8	Identification and distribution of CCK-related peptides and mRNAs in the rainbow trout, Oncorhynchus mykiss Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression ·Hanne Jensen, Ian J. Rourke, Morten Møller, Lars Jønson, Anders H. Johnsen	2001	55
9	Ischaemic heart disease in the dog: a review of 65 cases Journal of Small Animal Practice ·T. Falk, Lars Jønson	2000	55
10	Functional characterization of BRCA1 gene variants by mini-gene splicing assay European Journal of Human Genetics ·Ane Y. Steffensen, Mette Dandanell, Lars Jønson, Bent Ejlertsen, Anne‐Marie Gerdes, Finn C. Nielsen, Thomas van Overeem Hansen	2014	48
11	Next‐generation sequencing: proof of concept for antenatal prediction of the fetal Kell blood group phenotype from cell‐free fetal DNA in maternal plasma Transfusion ·Klaus Rieneck, Mads Bak, Lars Jønson, Frederik Banch Clausen, Grethe Risum Krog, Niels Tommerup, Leif Kofoed Nielsen, Morten Hedegaard, Morten Hanefeld Dziegiel	2013	47
12	Mutations in COA3 cause isolated complex IV deficiency associated with neuropathy, exercise intolerance, obesity, and short stature Journal of Medical Genetics ·Elsebet Østergaard, Woranontee Weraarpachai, Kirstine Ravn, Alfred Peter Born, Lars Jønson, Morten Dunø, Flemming Wibrand, Eric A. Shoubridge, John Vissing	2015	45
13	Germline Chromothripsis Driven by L1-Mediated Retrotransposition and Alu/Alu Homologous Recombination Human Mutation ·Lusine Nazaryan‐Petersen, Birgitte Bertelsen, Mads Bak, Lars Jønson, Niels Tommerup, Dustin C. Hancks, Zeynep Tümer	2016	42
14	Novel de novo BRCA2mutation in a patient with a family history of breast cancer BMC Medical Genetics ·Thomas van Overeem Hansen, Marie Luise Bisgaard, Lars Jønson, Anders Albrechtsen, Bettina Ekvall Filtenborg-Barnkob, Hans Eiberg, Bent Ejlertsen, Finn Cilius Nielsen	2008	33
15	Elasmobranchs express separate cholecystokinin and gastrin genes Proceedings of the National Academy of Sciences ·Anders H. Johnsen, Lars Jønson, Ian J. Rourke, Jens F. Rehfeld	1997	28
16	Splicing analysis of 14 BRCA1 missense variants classifies nine variants as pathogenic Breast Cancer Research and Treatment ·Lise Barlebo Ahlborn, Mette Dandanell, Ane Y. Steffensen, Lars Jønson, Finn C. Nielsen, Thomas van Overeem Hansen	2015	25
17	The silent mutation nucleotide 744 G → A, Lys172Lys, in exon 6 of BRCA2 results in exon skipping Breast Cancer Research and Treatment ·Thomas van Overeem Hansen, Ane Y. Steffensen, Lars Jønson, Mette Klarskov Andersen, Bent Ejlertsen, Finn C. Nielsen	2009	24
18	Malignant T cells express lymphotoxin α and drive endothelial activation in cutaneous T cell lymphoma Oncotarget ·Britt Lauenborg, Louise Dahl Christensen, Ulrik Ralfkiær, Katharina Kopp, Lars Jønson, Sally Dabelsteen, Charlotte M. Bonefeld, Carsten Geisler, Lise Mette Rahbek Gjerdrum, Qian Zhang, Mariusz A. Wasik, Elisabeth Ralfkiær, Niels Ødum, Anders Woetmann	2015	24
19	Enhanced peptide secretion by gene disruption of CYM1, a novel protease in Saccharomyces cerevisiae European Journal of Biochemistry ·Lars Jønson, Jens F. Rehfeld, Anders H. Johnsen	2004	23
20	Identification of six pathogenic RAD51C mutations via mutational screening of 1228 Danish individuals with increased risk of hereditary breast and/or ovarian cancer Breast Cancer Research and Treatment ·Lars Jønson, Lise Barlebo Ahlborn, Ane Y. Steffensen, Malene Djursby, Bent Ejlertsen, Susanne Timshel, Finn C. Nielsen, Anne‐Marie Gerdes, Thomas van Overeem Hansen	2016	22

About Lars Jønson

Lars Jønson is a scholar working on Molecular Biology, Genetics, Cancer Research, Pathology and Forensic Medicine and Genetics, having authored 36 papers that have together received 1.5k indexed citations. Recurring topics across this work include BRCA gene mutations in cancer (12 papers), CRISPR and Genetic Engineering (9 papers), DNA Repair Mechanisms (6 papers), Neuropeptides and Animal Physiology (4 papers), RNA Research and Splicing (4 papers), Lymphoma Diagnosis and Treatment (4 papers), Cancer Genomics and Diagnostics (4 papers) and Genomic variations and chromosomal abnormalities (4 papers). The work is most often cited by research in Cancer Research (338 citations), Dermatology (127 citations), Molecular Biology (878 citations), Genetics (256 citations) and Pathology and Forensic Medicine (164 citations). Lars Jønson has collaborated with scholars based in Denmark, United States and Greenland. Frequent co-authors include Thomas van Overeem Hansen, Finn Cilius Nielsen, Jan Christiansen, Jonas Vikesaa, Rehannah Borup, Ulla M. Wewer, Anders H. Johnsen, Bent Ejlertsen, T. Falk and Morten C. Kielland‐Brandt. Their work appears in journals such as Breast Cancer Research and Treatment, Familial Cancer, Oncotarget, Yeast and Transfusion.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact